Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Phase I
Biotech
HHS unveils plan to speed up ph. 1 trials by 6 to 12 months
The reforms are meant to hasten early clinical development and encourage companies to conduct trials in the U.S. rather than speedier locales.
Darren Incorvaia
Jun 22, 2026 12:10pm
United Therapeutics' temporary liver shows promise in trial
Jan 27, 2026 9:00am
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
Kura's leukemia drug works best when tacked onto existing combo
Jan 30, 2024 11:15am
Surrozen stops IBD program due to dose concerns and competition
Jan 18, 2024 9:55am
Jazz halts sleep disorder med trial over 'visual disturbances'
Nov 29, 2023 10:50am
